Skip to main content
OpenTrials
Completed

NCT Number: NCT07701265

Does Unilateral Compression Dressing Reduce Postoperative Swelling and Bruising After Upper Eyelid Blepharoplasty?

This study evaluated whether applying a compression dressing to one eyelid after upper eyelid blepharoplasty (eyelid lift surgery) reduces swelling, bruising, and discomfort compared to the untreated eyelid. In this randomized trial, each participant underwent bilateral upper eyelid blepharoplasty; after surgery, one eyelid was randomly assigned to receive a compression dressing for 24 hours, while the other eyelid received no dressing and served as the internal control. Outcomes including eyelid swelling, bruising, pain, aesthetic appearance, and corneal health were assessed by masked observers on postoperative days 1, 7, 30, and 90. The goal of this study was to determine whether routine use of compression dressing provides a measurable clinical benefit after this common cosmetic and functional eyelid surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Beyoglu Eye Training and Research Hospital

Istanbul, 34421, Turkey (Türkiye)

About this study

This was a prospective, randomized, controlled, observer-masked, within-subject (split-eye) trial conducted at a single academic center between June and November 2025. Adult patients with bilateral dermatochalasis scheduled for upper eyelid blepharoplasty were enrolled. Following bilateral surgery performed by a single surgeon, one eyelid of each patient was randomly assigned by coin toss to receive a compression dressing (folded sterile gauze secured with elastic tape, left in place for 24 hours), while the contralateral eyelid received no dressing and served as the internal control. All patients received standardized postoperative care, including bilateral cold compresses and topical medications.

Two masked investigators independently assessed postoperative edema (5-point ordinal scale), ecchymosis (ImageJ-based area quantification), and aesthetic outcome (Global Aesthetic Improvement Scale) from standardized clinical photographs obtained on postoperative days 1, 7, 30, and 90; disagreements were resolved by a third masked investigator. Postoperative pain (visual analog scale) and patient comfort preference were recorded on day 1. Best corrected visual acuity and corneal fluorescein staining (Oxford grading scale) were assessed at each follow-up visit to evaluate ocular surface safety. Between-group comparisons were performed using the Wilcoxon signed-rank test, with Holm-Bonferroni correction applied across outcomes at each visit to account for multiple comparisons.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients (≥18 years) with bilateral upper eyelid dermatochalasis scheduled for upper eyelid blepharoplasty
  • Willingness and ability to provide written informed consent
  • Ability to comply with the postoperative follow-up schedule (postoperative days 1, 7, 30, and 90)

Exclusion criteria

  • History of prior upper eyelid surgery
  • Unilateral dermatochalasis
  • Previous eyelid trauma
  • Congenital eyelid anomalies
  • Blepharochalasis syndrome
  • Coagulopathy
  • Combined indication for ptosis repair and blepharoplasty
  • Severe bilateral visual impairment precluding safe application of compression dressing

Treatment and study plan

Compression Dressing (CD)

Procedure

A compression dressing consisting of folded sterile gauze pads followed by a dry gauze layer, secured with elastic tape (Clivex®, Climed Healthcare, Türkiye), applied to one upper eyelid immediately after bilateral upper eyelid blepharoplasty and left in place for 24 hours. The contralateral eyelid remained uncovered and undressed, serving as the internal control.

No Dressing (Standard Postoperative Care)

Procedure

The contralateral upper eyelid received standard postoperative care without a compression dressing, remaining uncovered. All other postoperative treatments (topical antibiotic ointment, cooling protocol, medications) were identical to the compression dressing side.

Primary outcomes

  1. Postoperative eyelid edema

    Time frame: Postoperative day 1, postoperative day 7, postoperative day 30, postoperative day 90

    Standardized clinical photographs assessed by masked observers using a 5-point ordinal edema grading scale.

  2. Postoperative ecchymosis

    Time frame: Postoperative day 1, postoperative day 7, postoperative day 30, postoperative day 90

    Standardized clinical photographs analysed using ImageJ software and graded by masked observers.

Secondary outcomes

  1. Postoperative pain

    Time frame: Postoperative day 1

    Visual analogue scale (0-10)

  2. Patient comfort

    Time frame: Postoperative day 1

    Patient questionnaire comparing comfort between the compression dressing and control eyelids.

  3. Corneal staining

    Time frame: Postoperative days 1, 7, 30 and 90

    Fluorescein staining graded according to the Oxford grading scale.

  4. Global aesthetic improvement

    Time frame: Postoperative days 1, 7, 30 and 90

    Global Aesthetic Improvement Scale assessed by masked observers using standardized clinical photographs.

  5. Best corrected visual acuity

    Time frame: Baseline, postoperative days 1, 7, 30 and 90

    Best corrected visual acuity measured in logarithm of the minimum angle of resolution units.

Sponsors and collaborators

Lead sponsor

Fatma Poslu Karademir

Other Gov

Registry information

Official study title

The Effect of Compression Dressing on Postoperative Outcomes After Upper Eyelid Blepharoplasty: A Randomized, Controlled, Observer-Blinded Evaluation Study

Acronym: COMPRESS-BLEPH

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jul 14, 2026
Registry last updated
Jul 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.